Page last updated: 2024-09-04

febuxostat and Anemia, Sickle Cell

febuxostat has been researched along with Anemia, Sickle Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bachman, TN; Baust, JJ; Du, J; Ghosh, S; Hahn, SA; Kelley, EE; Lebensburger, JD; Lewis, SE; McMahon, B; Ofori-Acquah, SF; Oh, JY; Patel, RP; Schmidt, HM; Straub, AC; Vitturi, DA; Wang, Y; Williams, XM; Wood, KC; Yuan, S1

Other Studies

1 other study(ies) available for febuxostat and Anemia, Sickle Cell

ArticleYear
Xanthine Oxidase Drives Hemolysis and Vascular Malfunction in Sickle Cell Disease.
    Arteriosclerosis, thrombosis, and vascular biology, 2021, Volume: 41, Issue:2

    Topics: Anemia, Sickle Cell; Animals; Disease Models, Animal; Enzyme Inhibitors; Erythrocytes; Febuxostat; Hemodynamics; Hemolysis; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Pulmonary Artery; Ventricular Function; Xanthine Oxidase

2021